Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 54 for “"AD mouse models"”.

  1. Assessment of Memory in the DP(16)1YEY/+ Mouse Model of Down Syndrome

    … increases the risk of Alzheimer’s disease (AD), and a large percentage of people with DS develop AD neuropathology by the age of 40. To investigate the genetic contribution of trisomy 21 to DS phenotypes, including those related to AD pathology, a range of DS mouse models have been generated …

    queens Repository record for Assessment of Memory in the DP(16)1YEY/+ Mouse Model of Down Syndrome (opens in a new tab)

  2. CLEARANCE OF CAPILLARY OCCLUSIONS IMPROVES CORTICAL BLOOD FLOW AND COGNITIVE FUNCTION IN ALZHEIMER'S MOUSE MODELS

    Alzheimer disease (AD) is characterized by a loss of cognitive function caused by the dysfunction and death of neurons and other cells in the brain. This cell injury is largely due to the toxic effects of aggregates of amyloid-beta (Aβ), which accumulates into dense plaques in the brain. Research …

    cornell Repository record for CLEARANCE OF CAPILLARY OCCLUSIONS IMPROVES CORTICAL BLOOD FLOW AND COGNITIVE FUNCTION IN ALZHEIMER'S MOUSE MODELS (opens in a new tab)

  3. An exploration of amyloid-β seeding in mouse models of dementia

    Alzheimer’s disease (AD) is characterized by the prion-like propagation of misfolded proteins that appears dependent on the initial accumulation of amyloid-β (Aβ). But the role of Aβ in cognitive impairment is still unclear. To determine the causal role of Aβ in AD, mouse models expressing …

    lethbridge Repository record for An exploration of amyloid-β seeding in mouse models of dementia (opens in a new tab)

  4. Repurposing Rho-associated kinase (ROCK) inhibitors for the treatment of Alzheimer’s disease: it’s time to ROCK and Rho

    Alzheimer’s disease (AD) is a neurodegenerative disease that has no cure. AD is primarily characterized by extracellular amyloid-beta (Aβ)-containing neuritic plaques and intracellular phosphorylated tau-containing neurofibrillary tangles. There are medications available for AD patients. Examples …

    bu Repository record for Repurposing Rho-associated kinase (ROCK) inhibitors for the treatment of Alzheimer’s disease: it’s time to ROCK and Rho (opens in a new tab)

  5. Modulating behavior deficits in Alzheimer’s disease models by targeting interneurons

    Alzheimer’s Disease (AD) is the most common form of dementia and a multifaceted challenge. AD is represented by cognitive decline, memory deficits, and diversification in behavior. The hallmark pathological characteristics of AD include amyloid-beta plaques and phosphorylated tau tangles; however, …

    bu Repository record for Modulating behavior deficits in Alzheimer’s disease models by targeting interneurons (opens in a new tab)

  6. The Potential to Generate Exogenic Interneurons for Alzheimer’s Disease via Blastocyst Complementation

    Alzheimer’s disease (AD) currently affects millions of patients worldwide, and to date the development of effective therapies has been slow. In AD, numerous types of neural cells become dysfunctional and are susceptible to degeneration, leading to cognitive deficits. One particular cell type …

    umn Repository record for The Potential to Generate Exogenic Interneurons for Alzheimer’s Disease via Blastocyst Complementation (opens in a new tab)

  7. A Multi-Faceted Approach to the Alzheimer’s Disease Proteome: From Human to Mouse Models

    … is the central hallmark of Alzheimer’s disease (AD) and related dementias (ADRD). We analyzed the dementia with Lewy bodies disease (DLBD) proteome, a disorder also associated with amyloid pathology, and compared to the AD proteome, identifying conserved alterations in amyloid pathology and …

    tenn-hsc Repository record for A Multi-Faceted Approach to the Alzheimer’s Disease Proteome: From Human to Mouse Models (opens in a new tab)

  8. Comparative analysis of amyloid beta deposition in two different Alzheimer’s disease mouse models using whole-brain two-photon microscopy

    A variety of Alzheimer's disease (AD) mouse models express mutant forms of human amyloid precursor protein (APP), producing high levels of Aβ (Aβ) and forming plaques. However, the degree to which these models mimic spatiotemporal patterns of Aβ deposition in brains of people living with AD is …

    lethbridge Repository record for Comparative analysis of amyloid beta deposition in two different Alzheimer’s disease mouse models using whole-brain two-photon microscopy (opens in a new tab)

  9. The role of signaling lipids in the nervous system physiology and pathology: mechanistic insights of the phospholipase D pathway in neurodegenerative diseases

    … disorders, such as Alzheimer’s disease (AD). AD is the most common neurodegenerative disease and currently there is no effective treatment to tackle its progression. Therefore, a detailed understanding of its pathogenesis is critical to envision new therapeutic strategies. The main …

    minho-thes Repository record for The role of signaling lipids in the nervous system physiology and pathology: mechanistic insights of the phospholipase D pathway in neurodegenerative diseases (opens in a new tab)

  10. Enhancing Hippocampal Neurogenesis Rescues Cognitive Functions in Alzheimer’s Disease through Modulating the Neuronal Networks

    … and is mainly affected in Alzheimer’s disease (AD). AD is an irreversible neurodegenerative disease, characterized by pathological protein aggregations and cognitive impairments. To date, there is no treatment for Alzheimer’s disease. The search for a therapy is urgently needed to alleviate the …

    qucosa-diss

  11. Alzheimer's disease: a review of exercise as a protective function

    Alzheimer’s disease (AD) is the leading cause of dementia accounting for between 60-80% of all dementia related cases. It is the 6th leading cause of death in the US and is the only one in the top 10 leading causes of death without a prevention or cure. As the life-expectancy across the world …

    bu Repository record for Alzheimer's disease: a review of exercise as a protective function (opens in a new tab)

  12. Endothelial Vcam-1 As A Marker for Cerebrovascular Inflammation in Alzheimer’S Disease

    Alzheimer’s disease (AD) is a progressive neurodegenerative disease. Amyloid beta (Aβ) deposition and neurofibrillary tangles are two of the key pathological hallmarks of familial and sporadic forms of AD. Cerebrovascular inflammation is emerging as a third core feature of AD pathology. Activation …

    umn Repository record for Endothelial Vcam-1 As A Marker for Cerebrovascular Inflammation in Alzheimer’S Disease (opens in a new tab)

  13. CIS-Regulatory Elements: Relevance for Alzheimer's Disease

    Alzheimer’s disease (AD) is the most common neurodegenerative disease, currently affecting more than six million Americans with limited treatment options. Identifying genetics contributors to neurodegenerative diseases has contributed critical insights into potential disease mechanisms. The …

    uab Repository record for CIS-Regulatory Elements: Relevance for Alzheimer's Disease (opens in a new tab)

  14. A New Role for Beta-Amyloid in Alzheimer's Disease: Initiation of Thrombotic and Inflammatory Processes Via Coagulation Factor XII and Fibrinogen

    <p>Alzheimer's disease (AD) is a progressive neurodegenerative disorder with no effective therapies. While abundant genetic, histological, and experimental evidence links the beta-amyloid (Aβ) peptide to disease onset and progression, the mechanisms behind neuronal dysfunction in AD are not …

    rockefeller Repository record for A New Role for Beta-Amyloid in Alzheimer's Disease: Initiation of Thrombotic and Inflammatory Processes Via Coagulation Factor XII and Fibrinogen (opens in a new tab)

  15. The Role of PTP1B in Anxiety-Related Behaviours in hAPP-J20 and PS19 Mouse Models of Alzheimer’s Disease

    Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder amongst older adults. Features of this disease include accumulation of amyloid-β (Aβ) plaques, neurofibrillary tau tangles (NFT), neuroinflammation, and neurodegeneration. These result in a progressive decline in memory and …

    ottawa-retro Repository record for The Role of PTP1B in Anxiety-Related Behaviours in hAPP-J20 and PS19 Mouse Models of Alzheimer’s Disease (opens in a new tab)

  16. Epigenetic regulation by 5-hydroxymethylcytosine in atopic dermatitis and psoriasis and its implications for epidermal stem cell behavior

    … a healthy skin barrier by replenishing dead keratinocytes lost during daily turnover, injury, or pathological disturbances. In atopic dermatitis (AD) and psoriasis (PS), there is marked psoriasiform hyperplasia of the epidermis, suggesting a hyperproliferation of keratinocytes and …

    bu Repository record for Epigenetic regulation by 5-hydroxymethylcytosine in atopic dermatitis and psoriasis and its implications for epidermal stem cell behavior (opens in a new tab)

  17. Mechanisms of Memory Deficits in Mouse Models of Alzheimer's Disease

    Alzheimer’s disease (AD), a neurodegenerative disorder initially characterized by mild memory impairments, progresses to global cognitive deficits and eventually death. AD pathological hallmarks are plaques and tangles. Acute and chronic effects of familial Alzheimer’s disease (FAD) genes were …

    toronto-retro Repository record for Mechanisms of Memory Deficits in Mouse Models of Alzheimer's Disease (opens in a new tab)

  18. Neuronal Protection by a Novel C-terminal Hsp90 Modulator

    Alzheimer's disease (AD), like most neurodegenerative disorders, is characterized by accumulation of misfolded and aggregated proteins, indicating that the protein quality control machinery is compromised. Enhancing the activity of molecular chaperones such as the `heat shock' proteins (Hsp's) that …

    ku Repository record for Neuronal Protection by a Novel C-terminal Hsp90 Modulator (opens in a new tab)

  19. Therapeutic modulation of Alzheimer’s disease with biological (HUCBS) and pharmacological (LISPRO) approaches

    … the dementia spectrum, Alzheimer’s disease (AD) is the most common type of dementia that occurs with aging and accounts for about 60% - 80% of diagnosed cases. But currently available discoveries failed to develop disease-modifying therapies for all patients living with AD. Recent discoveries …

    usf Repository record for Therapeutic modulation of Alzheimer’s disease with biological (HUCBS) and pharmacological (LISPRO) approaches (opens in a new tab)

  20. IN VITRO BIOMATERIALS CELL CULTURE SYSTEMS: INVESTIGATING THE INFLUENCE OF STIFFNESS AND STRESS RELAXATION ON CELL MIGRATION, MICROGLIA ACTIVITIES, AND ALZHEIMER'S DISEASE MODELING

    … diseases like Alzheimer’s disease (AD). Also, the mechanical properties of the matrix have often been overlooked in the design of in vitro cell culture models. This dissertation investigates the relationship between the mechanical properties of ECM and cellular behavior, with a focus …

    jhu Repository record for IN VITRO BIOMATERIALS CELL CULTURE SYSTEMS: INVESTIGATING THE INFLUENCE OF STIFFNESS AND STRESS RELAXATION ON CELL MIGRATION, MICROGLIA ACTIVITIES, AND ALZHEIMER'S DISEASE MODELING (opens in a new tab) Embargoed until 2028-08-01

Page 1 of 3